Barclays reaffirmed their overweight rating on shares of Abivax (NASDAQ:ABVX – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $148.00 price objective on the stock. Other research analysts have also recently issued reports about the company. Wedbush raised their target price on Abivax from $90.00 to $110.00 and […]

Warner Bros. Discovery (NASDAQ:WBD – Get Free Report)‘s stock had its “equal weight” rating reissued by stock analysts at Barclays in a research note issued on Thursday, Benzinga reports. They presently have a $29.00 price target on the stock. Barclays‘s target price indicates a potential upside of 3.31% from the company’s previous close. Other equities […]